ArticleAsian Pacific journal of cancer prevention : APJCP2025
Innovation Culture in Oncology (IC-O) Scale: Psychometric Development and Validation Among Healthcare Professionals at a Comprehensive Cancer Center in Oman.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveInnovation culture plays a pivotal role in enhancing adaptability, care delivery, and strategic advancement in healthcare systems. Despite its critical importance, few validated instruments exist that are specifically tailored to measure innovation culture within healthcare organizations. This study aimed to develop and validate a 30-item Innovation Culture Scale, adapted for healthcare settings, especially oncology, capturing key organizational dimensions that influence innovation.
methodsA cross-sectional study was conducted in 2024 at the Sultan Qaboos Comprehensive Cancer Center (SQCCC), University Medical City, Muscat, Oman, involving 202 healthcare professionals. The questionnaire, grounded in the frameworks of Dobni (2008) and Tian et al. (2018), measured six latent constructs: Organizational Values and Culture, Leadership Behaviors, Resource Allocation, Innovation Processes, Organizational Climate, and Innovation Success. Psychometric assessments included descriptive statistics, internal consistency (Cronbach's alpha), Confirmatory Factor Analysis (CFA), and convergent validity through average variance extracted (AVE). Model fit was assessed using CFI, TLI, RMSEA, SRMR, and χ²/df.
resultsMean item scores ranged from 3.68 to 3.91 (SD = 0.59-0.72), indicating moderate to strong agreement with the scale items. All items exhibited acceptable skewness (-0.28 to +0.18) and kurtosis (-0.66 to +0.28), with high internal consistency across constructs (Cronbach's alpha = 0.831 to 0.884). CFA confirmed strong item loadings (>0.60), and the model demonstrated excellent fit: CFI = 0.962, TLI = 0.957, RMSEA = 0.042, SRMR = 0.035, and χ²/df = 1.87 (p = 0.062). AVE values ranged from 0.58 to 0.64, confirming convergent validity.
conclusionThe healthcare-adapted Innovation Culture Scale is a reliable and valid instrument for assessing innovation culture in clinical settings. Its application can support organizational assessment, leadership development, and strategic innovation planning aimed at enhancing quality, adaptability, and performance in oncology care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.